C11 BODIPY 581/591
目录号 : GC40165C11-BODIPY581/591是一种氧化敏感的荧光脂肪酸类似物,其荧光特性在可见光谱的红色范围内(发射峰值595nm),使其适用于荧光显微镜。
Cas No.:217075-36-0
Sample solution is provided at 25 µL, 10mM.
- Brain Res Bull 174 (2021): 250-259.PMID:34171402
- Acta Pharm Sin B 12.2 (2022): 692-707.PMID:35256940
- J Leukocyte Biol 110.2 (2021): 301-314.PMID:34318944
- Anal Chem 93.34 (2021): 11758-11764.PMID:34410685
- ACS Appl Mater Inter 13.45 (2021): 53671.PMID:34730938
- Front Mol Biosci 8 (2021): 725274.PMID:34568428
- Oxid Med Cell Longev 2021 (2021).PMID:34970416
- Eur J Pharmacol 919 (2022): 174797.PMID:35122867
- ACS nano 16.3 (2022): 3647-3663.PMID:35266697
- Transl Cancer Res 11.5 (2022): 1173.PMID:35706810
- J Nanobiotechnol 20.1 (2022): 230.PMID:35568865
- Chin Med-UK 17.1 (2022): 82.PMID:35787281
- Biomed Pharmacother 154 (2022): 113572.PMID:35988428
- Biochem Bioph Res Co 627 (2022): 103-110.PMID:36030651
- Life Sci 308 (2022): 120925.PMID:36057399
- Ebiomedicine 84 (2022).PMID:36137413
- Plos one 17.11 (2022): e0276083.PMID:36355759
- Cells 11.22 (2022): 3580.PMID:36429010
- Eur J Pharm Sci 181 (2023): 106350..PMID:36496165
- Redox Biol 59 (2023): 102564.PMID:36473315
- Cancer Lett 554 (2023): 216033.PMID:36493901
- Sci Total Environ 855 (2023): 158715.PMID:36113792
- J Exp Clin Canc Res 42.1 (2023): 1-19.PMID:36604718
- Chem Eng J 454 (2023): 140044.
- Free Radical Bio Med 195 (2023): 329-342.PMID:36610561
- Molecules 28.8 (2023): 3389.PMID:37110625
- Chem Eng J 466 (2023): 143012.
- Free Radical Bio Med 204 (2023): 226-242.PMID:37146698
- Acta Biomater (2023).PMID:37156432
- Chem Res Chinese U (2023): 1-6.
- Biochem Pharmacol 213 (2023): 115592.PMID:37196680
- J Nanobiotechnol 21.1 (2023): 1-19.PMID:37316835
- Int J Mol Med 52.5 (2023): 1-14.PMID:37800609
- Biochem Cell Biol 100.5 (2022): 378-386.PMID:35785548
- Cell Death Discov 8.1 (2022): 431.PMID:36307402
- Eur J Neurosci 58.1 (2023): 2194-2214.PMID:37161649
- Front Cell Neurosci 16 (2022): 774297.PMID:35431808
- Front Mol Biosci 9 (2022): 860525.PMID:35860356
- Front Oncol 11 (2022): 802124.PMID:35127512
- J Nanobiotechnol 20.1 (2022): 1-15.PMID:36109814
- J Biochem Mol Toxic (2023): e23542.PMID:37712196
- Method Protocol (2023): 165-178.PMID:37578705
- Eur J Neurosci 58.1 (2023): 2194-2214.PMID:37161649
- Exp Ther Med 26.5 (2023): 1-15.PMID:37869642
- J Pharm Anal (2023).
- The Prostate (2023).PMID:37750290
- Int Immunopharmacol 127 (2024):111377.PMID:38104369
- Redox Rep 29.1 (2024):2290864.PMID:38149613
- Bioact Mater 33 (2024):483-496.PMID:38125638
- Biochem Bioph Res Co 690 (2024):149274.PMID:37995455
- J Mater Chem B (2024).PMID:38063821
- Biol Trace Elem Res (2024):1-11.PMID:38183555
- J Orthop Transl 44 (2024):114-124.
- J Mol Struct (2024):137668.
- Cell Signal (2024):111108.PMID:38369266
- J Funct Foods 113 (2024):106018.
- Kaohsiung J Med Sci (2024).PMID:38340032
- Pharm Biol 62.1 (2024):195-206.PMID:38339810
- Research (2024).PMID:38371274
- Cell Death Differ (2024):1-16.PMID:38418695
- Carcinogenesis (2024):bgae016.PMID:38422369
- Int J Biol Sci 20.5 (2024):1707.PMID:38481805
- bioRxiv (2024):2024-03.
- Sci Total Environ (2024):171818.PMID:38508245
- Appl Organomet Chem (2024):e7456.
- Heliyon (2024).
- Antioxid Redox Sign (2024).PMID:38545792
- Biomed Pharmacother 174 (2024):116542.PMID:38574620
- Bone Res 12.1 (2024):20.PMID:38553442
- Cancer Lett (2024):216826.PMID:38574881
- Heliyon (2024).PMID:38576562
- Free Radical Bio Med (2024).PMID:38614226
- Bmc Cancer 24.1 (2024):1-15.PMID:38637761
- Antioxid Redox Sign (2024).PMID:38545792
- Bmc Cancer 24.1 (2024):496.PMID:38637761
- Int Immunopharmacol 134 (2024):112177.PMID:38696908
- J Cell Mol Med 28.8 (2024):e18335.PMID:38652216
- J Exp Clin Canc Res 43.1 (2024):1-20.PMID:38745179
- J Ethnopharmacol (2024):118363.PMID:38763373
- Biomacromolecules (2024).PMID:38779908
- Mol Cancer 23.1 (2024):113.PMID:38802795
- Nat Commun 15.1 (2024):4760.PMID:38834654
- Biochem Pharmacol (2024):116345.PMID:38852643
- Heliyon (2024).
- Environ Res (2024):119483.PMID:38914254
- J Nanobiotechnol 22.1 (2024):353.PMID:38902759
- Sci Rep-Uk 14.1 (2024):15246.PMID:38956068
- J Nanobiotechnol 22.1 (2024):390.PMID:38961442
- Sci Total Environ (2024):174532.PMID:38972417
- Free Radical Bio Med (2024).PMID:38996820
- Int J Biol Macromol (2024):134149.
- Nutrients 16.14 (2024):2314.
- Clin Transl Oncol (2024):1-13.PMID:39060774
- Front Pharmacol 15 (2024):1440147.PMID:37059385
- J Control Release 373 (2024):599-616.PMID:39074587
- Cell Death Dis 15.8 (2024):611.PMID:39174525
- Chem Eng J (2024):155019.
- Mol Med 30.1 (2024):1-18.PMID:39266965
- Cell Death Dis 15.8 (2024):611.PMID:39174525
- Arch Med Sci (2024).
- Npj Biofilms Microbi 10.1 (2024):102.PMID:39370453
- Adv Sci (2024):2406343.PMID:39420512
- Biol Direct 19.1 (2024):1-16.PMID:39438996
- Drug Resist Update (2024):101171.PMID:39531951
- Toxicology (2024):153996.PMID:39532264
- Cell Death Dis 15.11 (2024):826.PMID:39543094
- J Cell Mol Med 28.22 (2024):e70236.PMID:39601332
C11-BODIPY581/591 is an oxidation-sensitive fluorescent fatty acid analogue with fluorescent properties in the red range of the visible spectrum (emission maximum 595 nm), allowing its application in fluorescence microscopy. C11-BODIPY581/591 is easily incorporating into membranes and fluoresces red in the intact state but shifts to green upon free radical-induced oxidation. This characteristic is highly advantageous, it makes the ratio-imaging of oxidant activities at the (sub)cellular level feasible. In addition, the fluorescent properties of C11-BODIPY581/591 allow the use of this probe in fast- and medium- throughput screening of antioxidants in living cells and model membranes in a multiwell/fluorescence reader approach[1][2].
The wavelengths of maximal excitation and emission of fluorophore C11-BODIPY581/591 corresponded to 581 and 591 nm, respectively. Addition of CumOOH/hemin, as an initiator of lipid oxidation, shifted the excitation and emission spectra to shorter wavelengths corresponding to green fluorescence (peak excitation 500 nm, emission 510 nm). C11-BODIPY581/591 is also easily oxidized by other hydroxy-, peroxy- and oxy-radical generating systems such as hydrogen peroxide/Fe2+ and 2,2’-azobis. However, this probe is relatively insensitive to SIN-1, which generates nitric oxide and superoxide[3]
References:
[1]. Drummen GP, et al. C11-BODIPY581/591, an oxidation-sensitive fluorescent lipid peroxidation probe: (micro)spectroscopic characterization and validation of methodology. Free Radic Biol Med. 2002 Aug 15;33(4):473-90.
[2]. Partyka A, et al. Detection of lipid peroxidation in frozen-thawed avian spermatozoa using C11-BODIPY581/591. Theriogenology. 2011 Jun;75(9):1623-9.
[3]. Pap EH, et al. Ratio-fluorescence microscopy of lipid oxidation in living cells using C11-BODIPY581/591. FEBS Lett. 1999 Jun 25;453(3):278-82.
本方案仅提供一个指导,请根据您的具体需要进行修改。
1.染色液的制备
(1)配置储存液:使用DMSO溶解C11 BODIPY 581/591,配置浓度为1-10mM的储存液。
注意:未使用的储存液分装后在-20℃或-80°C避光保存,避免反复冻融。
(2)配置工作液:用合适的缓冲液(如:无血清培养基或PBS)稀释储存液,配制浓度为1-10μM的工作液。
注意:请根据实际情况调整工作液浓度,现用现配。
2.细胞悬浮染色
(1)悬浮细胞:经4°C、1000g离心3-5分钟,弃去上清液,用PBS清洗两次,每次5分钟。
(2)贴壁细胞:使用PBS清洗两次,加入胰酶消化细胞,消化完成后经1000g离心3-5min。
(3)加入1mL的C11 BODIPY 581/591工作溶液重悬细胞,37 °C避光孵育5-30分钟。不同细胞最佳孵育时间不同,请根据具体实验需求自行摸索。
(4)孵育结束后,经1000g离心5分钟,去除上清液,加入PBS清洗2-3次,每次5分钟。
(5)用预温的无血清细胞培养基或PBS重悬细胞,通过荧光显微镜或流式细胞术观察。
3.细胞贴壁染色
(1)在无菌盖玻片上培养贴壁细胞。
(2)从培养基中移走盖玻片,吸出过量的培养基,将盖玻片放在潮湿的环境中。
(3)从盖玻片的一角加入100μL的染料工作液,轻轻晃动使染料均匀覆盖所有细胞。
(4) 37 °C避光孵育5-30分钟。不同细胞最佳孵育时间不同,请根据具体实验需求自行摸索。
(5)孵育结束后吸弃染料工作液,使用预温的培养液清洗盖玻片2~3次。
4.显微镜检测:C11 BODIPY 581/591氧化型的激发光和发射光分别为460-495nm和510-550nm;还原型的激发光和发射光分别为565-581nm和585-591nm。
注意事项:
1)荧光染料均存在淬灭问题,请尽量注意避光,以减缓荧光淬灭。
2)为了您的安全和健康,请穿实验服并戴一次性手套操作。
Cas No. | 217075-36-0 | SDF | |
化学名 | (T-4)-difluoro[5-[[5-[(1E,3E)-4-phenyl-1,3-butadien-1-yl]-2H-pyrrol-2-ylidene-κN]methyl]-1H-pyrrole-2-undecanoato(2-)-κN1]-borate(1-), monohydrogen | ||
Canonical SMILES | [F-][B+3]1([N]2=C(/C=C/C=C/C3=CC=CC=C3)C=CC2=CC4=CC=C(CCCCCCCCCCC([O-])=O)[N-]14)[F-].[H+] | ||
分子式 | C30H34BF2N2O2 • H | 分子量 | 504.4 |
溶解度 | 30mg/ml in DMSO,Slightly soluble in Methanol | 储存条件 | Store at -20°C; protect from light |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 1.9826 mL | 9.9128 mL | 19.8255 mL |
5 mM | 0.3965 mL | 1.9826 mL | 3.9651 mL |
10 mM | 0.1983 mL | 0.9913 mL | 1.9826 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >97.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
-
Related Biological Data
Intracellular ferroptosis evaluations. d) CLSM images of C11-BODIPY581/591-stained 4T1 cells after CMS treatment (scale bar = 20 μm).
C11-BODIPY581/591 was purchased from GLPBIO.
Bioactive Materials, 2024, 33: 483-496. PMID: 38125638 IF: 18.8997 -
Related Biological Data
GSS contributes to GBM cell resistance to radiotherapy-induced ferroptosis. (J) Confocal microscopy visualized the alterationsin lipid peroxidation in LN229 cells after C11-BODIPY probe staining.
The C11 BODIPY 581/591 assay kit (GLPBIO, USA, GC40165) was used following the manufacturer’s manual.
ACS nano, 2023. PMID: 37646615 IF: 17.0997 -
Related Biological Data
Mechanisms of action studies of RF@LA-Fe-MOF. (b) LPO levels in C5WN1 cells after incubated with RF@LA-Fe-MOF (5 or 10μg mL-1) for 12 h.
Cells were stained with C11-BODIPY581/591 (5 × 10-6 M) (GlpBio, USA)for 10 min in PBS (pH 7.4) solution and imaged by CLSM.
Chem Eng J 454 (2023): 140044. IF: 16.7438 -
Related Biological Data
Ferroptosis-inducing ability of Cu2−XS-GOx@CaCO3. (E) LPO detection within treated cells.
Afterwards, the treated cells were stained with C11-BODIPY 581/591 (GlpBio Technology) and incubated for 30 min.
Chem Eng J (2023): 143012. IF: 16.7438 -
Related Biological Data
Mechanism of DFMC induced ferroptosis. (e) LPO level of CT26 cells incubated with DFMC.
Following the protocol of the product for the next steps, the media were replaced with the diluted C11-BODIPY581/591 (GlpBio, USA) staining solution, and incubated for 20 min.
ACS nano (2022). PMID: 35266697 IF: 15.8814 -
Related Biological Data
BPQDs cause ferroptosis in lung A549 cells. The lipid peroxidation level was measured with C11 BODIPY staining as detected using D) fluorescent images.
Briefly, cells were incubated in six-well plates with BPQDs for 24h, and then washed with cold phosphate buffer saline (PBS) three times and incubated with C11 BODIPY 581/591(GlpBio, USA) for 30 min at 37°C.
Small Methods (2021): 2001045. PMID: 3492782 IF: 14.18